Activity value 72china Supplier,Last transaction date:
2025-12-09
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for shandong new time pharma co.ltd. from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 2 transactions, with a transaction quantity of 3365 and a transaction weight of 0.
YearTransactionsQuantityWeight
2024000
2025233650
Bill of lading data
<
1/15
>
Trade date
2025/12/09
B/L No.
——
Suppliers
shandong new time pharma co.ltd.
Buyers
sami pharmaceutical pvt ltd.
POLs
——
PODs
kpaf
Supply area
China
Purchas area
Pakistan
Weight
——
Amount
2783.47
Hs code
29322090
Product tags
pharmaceutical raw material,orlistat
Product description
(PHARMACEUTICAL RAW MATERIAL) ORLISTAT USP.
Expand
Trade date
2025/03/28
B/L No.
——
Suppliers
shandong new time pharma co.ltd.
Buyers
cinarazi pharma
4obs pakistan pvt
pakistanbuyer,they trade on 2019-06-16
24.35%
>
5abs enterprises
indiasupplier,they trade on 2021-01-26
12.17%
>
+View All
Products
Total 6
ProductsTransactionsPerDetail
gimeracil 1100%>
oteracil potassium 1100%>
cancer treatment 1100%>
capsule 1100%>
medicine 1100%>
+View All
Hscode rank
Total 2
HSCode NameTransactionsPerDetail
HS 300490991100%>
Trading Area
Total 1
AreaTransactionsPerDetail
pakistan46100%>
Port statistics
Total 8
Port NameTransactionsPerDetail
beijing capital inte919.57%>
bankok36.52%>
metropolitan area th36.52%>
bangkok24.35%>
colombo24.35%>
+View All
shandong new time pharma co.ltd. is china Supplier,
and primarily engages in the import and export business of products such as gimeracil,oteracil potassium,cancer treatment.
According to the 52wmb.com global trade database, as of 2025-12-09, the company has completed 46 international trades,
with its main trading regions covering pakistan etc.
The core products include HS30049099 etc,
often transported via beijing capital inte,port bankok, port metropolitan area th etc,
and its main trading partners are bosch pharmaceutical pvt ltd.,zafa pharmaceutical laboratories 9 pvt ltd.,stallion parmaceuticals pvt ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on shandong new time pharma co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.